Skip to content

patientorientend.graduated.interdisciplinary.network-treatment

patientorientend.graduated.interdisciplinary.network-treatment - PAIN2.0

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030773
Enrollment
1029
Registered
2022-11-21
Start date
2023-01-02
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent pain episodes with risk for chronification

Interventions

Group 1: Intervention group Intervention takes place immediately after randomization
10-week outpatient interdisciplinary group therapy (3h/week, plus medical, physiotherapeutic and psychological individual) and a joint final session of all professions with the patients Initial surve

Sponsors

Deutsche Schmerzgesellschaft e.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - (at least 6 weeks ago) newly occurring pain or pain that has occurred repeatedly or persisted for a longer period of time - pain-related restrictions relevant to the person affected (possibly already occurring AU, impairment in everyday life/family/leisure time and (home) work), as well as associated deterioration in the quality of life - a risk of chronification (e.g. spreading pain, stress factors in family and work, pronounced sparing and avoidance behavior): - Participants in the study are at least 18 years of age, have sufficient knowledge of written and spoken German, live within reach of the participating facility, and have given verbal and written consent to participate in advance. - Participants are insured with a GKV health insurance company.

Exclusion criteria

Exclusion criteria: Primary exclusion criteria are clinical indications of a serious illness requiring urgent acute therapy "red flags", or other acutely effective serious illnesses that prevent activating treatment (e.g. severe heart failure, tumor); a manifest chronic pain illness that has already occurred (e.g. AU due to pain for longer than 6 months, previous IMST in the last two years). (e.g., sick leave due to pain for more than 6 months, previous therapy with strong opioids lasting more than 6 months, previous IMST in the last two years); a severe and active psychiatric disorder (personality disorder, severe depression, indications of suicidal tendencies); an ongoing pension procedure or rehabilitation procedure planned in the near future; linguistic and/or cognitive impairments; ongoing diagnostics and/or therapy with regard to pain-specific pathology (in these cases, the result should first be awaited). Patients undergoing treatment under the terms of the employers' liability insurance association and with private health insurance are to be excluded.

Design outcomes

Primary

MeasureTime frame
Primary end point Pain intensity (von Korff Chronic Pain Grading Questionnaire, characteristic pain intensity) Pain-related impairment (von Korff Chronic Pain Grading Questionnaire) Assessment: Baseline, follow-up 3,6,9,12 months. the primary evaluation approach refers to the survey time points at baseline to 6 months post-survey

Secondary

MeasureTime frame
Secondary endpoints: Days of incapacity to work, sick pay, sickness costs (BARMER Wissenschafts-Data-Ware-House, secondary data, survey 6 months after intervention). Psychological distress (depression-anxiety-stress scale) Health-related quality of life V(eterans RAND 12-Item Health Survey). Catastrophizing (Pain Catastrophizing Scale). Psychosocial Factors Assessment at Baseline, Follow up 3,6,9,12 months.

Countries

Germany

Contacts

Public ContactFelix Rottke

Deutsche Schmerzgesellschaft e.V.

rottke@schmerzgesellschaft.de+49 30 39409689-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026